OXiGENE Financial Statements
OXiGENE Financial Information
| Company Type | Public Single Location |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
OXiGENE Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (22.3) | (17.9) | (13.1) |
| Total Net Income ($ mil.) | (20.4) | (15.5) | (11.9) |
| Diluted EPS (Net Income) | (0.73) | (0.56) | (0.61) |
OXiGENE Quarterly Statements
| Quarter Ending Sep 08 | Quarter Ending Jun 08 | Quarter Ending Mar 08 | |
|---|---|---|---|
| Revenue ($ mil.) | 0.0 | 0.0 | 0.0 |
| Gross Profit ($ mil.) | -- | -- | -- |
| Operating Income ($ mil.) | (7.2) | (7.2) | (5.7) |
| Total Net Income ($ mil.) | (7.1) | (7.1) | (5.4) |
| Diluted EPS (Net Income) | (0.25) | (0.25) | (0.19) |
OXiGENE Stock Quote & Chart
12/02/08 11:02:29 EST •
NASDAQ •
0.71
•
 +0.0100
•
+1.4286 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
OXiGENE Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 1,244.85 | 2.15 | 0.92 |
| Price/Earnings Ratio | -- | 10.45 | 10.39 |
| Price/Book Ratio | 3.19 | 1.61 | 0.88 |
| Price/Cash Flow Ratio | -- | 8.74 | 5.82 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed OXiGENE Financial Ratios
OXiGENE Competitive Intelligence
| AstraZeneca | Genentech | Sanofi-Aventis | |
|---|---|---|---|
| Annual Sales ($ mil.) | -- | 11,724.0 | 43,019.0 |
| Employees | -- | 11,174 | 99,495 |
| Market Cap ($ mil.) | -- | 76,525.0 | -- |
Competitive Landscape
